Incorporating (18)FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation

BACKGROUND: To investigate whether the incorporation of (18)FDG-PET into the automatic treatment planning process may be able to decrease the dose to active bone marrow (BM) for locally advanced anal cancer patients undergoing concurrent chemo-radiation (CHT-RT). METHODS: Ten patients with locally a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Franco, Pierfrancesco, Fiandra, Christian, Arcadipane, Francesca, Trino, Elisabetta, Giglioli, Francesca Romana, Ragona, Riccardo, Ricardi, Umberto
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Technical Advance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668955/
https://ncbi.nlm.nih.gov/pubmed/29096619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3708-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars